Guillain-Barré Syndrome

作者: Mazen M. Dimachkie , Richard J. Barohn

DOI: 10.1007/S11940-013-0231-Z

关键词:

摘要: Acute Inflammatory polyneuropathies are an important group of neuromuscular disorders and referred to collectively as Guillain-Barre syndrome (GBS). Our knowledge regarding pathogenesis, diagnosis management continues expand, resulting in improved opportunities for identification treatment. These autoimmune processes cause neuropathy by affecting various structures (myelin or axons), at different locations (nerve root, nerve cell bodies peripheral nerve) with a variety patterns. Most clinical neurologists will be involved the patients these disorders, there now reasonable therapies available acquired demyelinating neuropathies. In this report, we review distinctive clinical, laboratory electro-diagnostic features that aid their diagnosis, emphasis on characteristics paramount importance diagnosing specific conditions determining most appropriate therapies, helpful long-term prognosis.

参考文章(96)
R Rüdel, H H Kornhuber, H Brinkmeier, K H Wollinsky, P J Hülser, H H Mehrkens, Filtration of cerebrospinal fluid in acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome). Annales De Medecine Interne. ,vol. 145, pp. 451- 458 ,(1994)
L. H. Visser, F. G. A. Van Der Meché, P. A. Van Doorn, J. Meulstee, B. C. Jacobs, P. G. Oomes, R. P. Kleyweg, Guillain-Barré syndrome without sensory loss (acute motor neuropathy)A subgroup with specific clinical, electrodiagnostic and laboratory features Brain. ,vol. 118, pp. 841- 847 ,(1995) , 10.1093/BRAIN/118.4.841
TW Ho, CY Li, DR Cornblath, CY Gao, AK Asbury, JW Griffin, GM McKhann, None, Patterns of recovery in the Guillain-Barre syndromes Neurology. ,vol. 48, pp. 695- 700 ,(1997) , 10.1212/WNL.48.3.695
Satoshi Kuwabara, Nobuhiro Yuki, Michiaki Koga, Takamichi Hattori, Daisuke Matsuura, Masami Miyake, Masatoshi Noda, IgG Anti‐GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain‐barré syndrome Annals of Neurology. ,vol. 44, pp. 202- 208 ,(1998) , 10.1002/ANA.410440210
Philip M. Goodhew, Heather M. Johnston, Immune globulin therapy in children with Guillain‐Barré syndrome Muscle & Nerve. ,vol. 19, pp. 1490- 1492 ,(1996) , 10.1002/(SICI)1097-4598(199611)19:11<1490::AID-MUS16>3.0.CO;2-X
E. R. Bickerstaff, P. C. P. Cloake, Mesencephalitis and Rhombencephalitis BMJ. ,vol. 2, pp. 77- 81 ,(1951) , 10.1136/BMJ.2.4723.77
M. K. Sharief, D. A. Ingram, M. Swash, E. J. Thompson, IV immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome Neurology. ,vol. 52, pp. 1833- 1833 ,(1999) , 10.1212/WNL.52.9.1833
L. H. Visser, F.G.A. van der Meche, J. Meulstee, P. Rothbarth, B. C. Jacobs, P. I.M. Schmitz, P. A. van Doorn, Cytomegalovirus infection and Guillain-Barre syndrome: The clinical, electrophysiologic, and prognostic features Neurology. ,vol. 47, pp. 668- 673 ,(1996) , 10.1212/WNL.47.3.668
Charles A. Thornton, Robert C. Griggs, Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease Annals of Neurology. ,vol. 35, pp. 260- 268 ,(1994) , 10.1002/ANA.410350304